In vivo anti-tumor effect of hybrid vaccine of dendritic cells and esophageal carcinoma cells on esophageal carcinoma cell line 109 in mice with severe combined immune deficiency

Figure 3 No formation of tumor in the liver (A), in the kidney 60 d after injection of EC109-DC into the vena caudalis (B) (HE, 20 × 10) and in tumor tissue (C) of SCID mice 28 d after injection of EC109 into the abdominal cavity (HE, 10 × 10).